{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T02:52:38Z","timestamp":1790218358791,"version":"4.1.0"},"reference-count":66,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T00:00:00Z","timestamp":1742342400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011948","name":"Abbott Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011948","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cjcopen.ca","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["CJC Open"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.cjco.2025.03.015","type":"journal-article","created":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T11:12:54Z","timestamp":1742814774000},"page":"813-820","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Heart Transplant and Durable Mechanical Circulatory Support for Specific Less-Common Cardiomyopathies"],"prefix":"10.1016","volume":"7","author":[{"given":"Ana","family":"Roussouli\u00e8res","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Farrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Finn","family":"Gustafsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Kittleson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mrudula","family":"Munagala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Stehlik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjco.2025.03.015_bib1","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.healun.2019.08.003","article-title":"The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: twenty-second pediatric lung and heart-lung transplantation report-2019; focus theme: donor and recipient size match","volume":"38","author":"Hayes","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cjco.2025.03.015_bib2","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.athoracsur.2023.11.004","article-title":"The Society of Thoracic Surgeons Intermacs 2023 annual report: focus on magnetically levitated devices","volume":"117","author":"Jorde","year":"2024","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.cjco.2025.03.015_bib3","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/j.healun.2022.07.018","article-title":"The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: thirty-ninth adult heart transplantation report-2022; focus on transplant for restrictive heart disease","volume":"41","author":"Hsich","year":"2022","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cjco.2025.03.015_bib4","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1016\/j.jacc.2020.04.045","article-title":"Outcomes in patients with hypertrophic cardiomyopathy and left ventricular systolic dysfunction","volume":"75","author":"Rowin","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjco.2025.03.015_bib5","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1161\/CIRCHEARTFAILURE.114.001843","article-title":"Clinical spectrum, therapeutic options, and outcome of advanced heart failure in hypertrophic cardiomyopathy","volume":"8","author":"Pasqualucci","year":"2015","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cjco.2025.03.015_bib6","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1161\/CIRCHEARTFAILURE.114.001435","article-title":"Advanced heart failure with preserved systolic function in nonobstructive hypertrophic cardiomyopathy: under-recognized subset of candidates for heart transplant","volume":"7","author":"Rowin","year":"2014","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cjco.2025.03.015_bib7","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1161\/CIRCULATIONAHA.113.007094","article-title":"Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy","volume":"130","author":"Chan","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.cjco.2025.03.015_bib8","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1161\/CIRCHEARTFAILURE.114.002248","article-title":"Cardiopulmonary exercise testing and prognosis in hypertrophic cardiomyopathy","volume":"8","author":"Coats","year":"2015","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cjco.2025.03.015_bib9","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.ahj.2015.02.006","article-title":"Predictors of long-term outcomes in patients with hypertrophic cardiomyopathy undergoing cardiopulmonary stress testing and echocardiography","volume":"169","author":"Masri","year":"2015","journal-title":"Am Heart J"},{"key":"10.1016\/j.cjco.2025.03.015_bib10","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.jchf.2023.07.004","article-title":"Advanced heart failure therapies for hypertrophic cardiomyopathy: state-of-the-art review and an updated analysis from UNOS","volume":"11","author":"Liang","year":"2023","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cjco.2025.03.015_bib11","first-page":"e558","article-title":"2020 AHA\/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"142","author":"Ommen","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.cjco.2025.03.015_bib12","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1111\/ajt.16325","article-title":"Changes in heart transplant waitlist and posttransplant outcomes in patients with restrictive and hypertrophic cardiomyopathy with the new heart transplant allocation system","volume":"21","author":"Loyaga-Rendon","year":"2021","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cjco.2025.03.015_bib13","first-page":"69","article-title":"Review of the allocation criteria for heart transplant in Spain in 2023. SEC-Heart Failure Association\/ONT\/SECCE consensus document","volume":"77","author":"Spain Gonz\u00e1lez-Costello","year":"2024","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"10.1016\/j.cjco.2025.03.015_bib14","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.117.004378","article-title":"Outcomes in patients with hypertrophic cardiomyopathy awaiting heart transplantation","volume":"11","author":"Zu\u00f1iga Cisneros","year":"2018","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cjco.2025.03.015_bib15","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.recesp.2023.10.006","article-title":"Prognosis after heart transplant in patients with hypertrophic and restrictive cardiomyopathy. A nationwide registry analysis","volume":"77","author":"Gonz\u00e1lez-Urbistondo","year":"2024","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"10.1016\/j.cjco.2025.03.015_bib16","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.cardfail.2017.09.011","article-title":"Outcomes of restrictive and hypertrophic cardiomyopathies after LVAD: an INTERMACS analysis","volume":"23","author":"Patel","year":"2017","journal-title":"J Card Fail"},{"key":"10.1016\/j.cjco.2025.03.015_bib17","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/MAT.0000000000001238","article-title":"Left ventricular assist device implantation in hypertrophic and restrictive cardiomyopathy: a systematic review","volume":"67","author":"Sreenivasan","year":"2021","journal-title":"ASAIO J"},{"key":"10.1016\/j.cjco.2025.03.015_bib18","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.jacc.2020.06.038","article-title":"Long-term adverse cardiac outcomes in patients with sarcoidosis","volume":"76","author":"Yafasova","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjco.2025.03.015_bib19","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCULATIONAHA.114.011522","article-title":"Cardiac sarcoidosis: epidemiology, characteristics, and outcome over 25 years in a nationwide study","volume":"131","author":"Kandolin","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.cjco.2025.03.015_bib20","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1161\/CIRCULATIONAHA.123.066962","article-title":"End-stage heart failure in cardiac sarcoidosis","volume":"149","author":"Velikanova","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.cjco.2025.03.015_bib21","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.cardfail.2018.02.009","article-title":"A contemporary analysis of heart transplantation and bridge-to-transplant mechanical circulatory support outcomes in cardiac sarcoidosis","volume":"24","author":"Crawford","year":"2018","journal-title":"J Card Fail"},{"key":"10.1016\/j.cjco.2025.03.015_bib22","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1016\/S0828-282X(09)70484-2","article-title":"Do clinical diagnoses correlate with pathological diagnoses in cardiac transplant patients? The importance of endomyocardial biopsy","volume":"25","author":"Luk","year":"2009","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjco.2025.03.015_bib23","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.healun.2021.08.012","article-title":"Heart transplantation outcomes in cardiac sarcoidosis","volume":"41","author":"Jackson","year":"2022","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cjco.2025.03.015_bib24","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1002\/ehf2.13789","article-title":"Outcomes after heart transplantation in patients with cardiac sarcoidosis","volume":"9","author":"Asleh","year":"2022","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.cjco.2025.03.015_bib25","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1016\/j.healun.2005.02.016","article-title":"Recurrence of cardiac sarcoidosis in a heart transplant recipient","volume":"24","author":"Yager","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cjco.2025.03.015_bib26","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s00392-019-01485-z","article-title":"Recurrent cardiac sarcoidosis after heart transplantation","volume":"108","author":"Veronese","year":"2019","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.cjco.2025.03.015_bib27","doi-asserted-by":"crossref","DOI":"10.1093\/ejcts\/ezab480","article-title":"The impact of left ventricular size on outcomes after centrifugal-flow left ventricular assist device implantation","volume":"62","author":"Molina","year":"2022","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.cjco.2025.03.015_bib28","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1007\/s00392-021-01958-0","article-title":"Lessons learned from catheter ablation of ventricular arrhythmias in patients with a fully magnetically levitated left ventricular assist device","volume":"111","author":"Bergau","year":"2022","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.cjco.2025.03.015_bib29","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.jacep.2018.05.006","article-title":"Predictors and clinical impact of late ventricular arrhythmias in patients with continuous-flow left ventricular assist devices","volume":"4","author":"Galand","year":"2018","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.cjco.2025.03.015_bib30","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.cardfail.2021.07.025","article-title":"Characteristics and outcomes of patients with inflammatory cardiomyopathies receiving mechanical circulatory support: an STS-INTERMACS Registry analysis","volume":"28","author":"Sheikh","year":"2022","journal-title":"J Card Fail"},{"key":"10.1016\/j.cjco.2025.03.015_bib31","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jchf.2022.10.012","article-title":"How to identify cardiac amyloidosis patients who might benefit from cardiac transplantation","volume":"11","author":"Ambardekar","year":"2023","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cjco.2025.03.015_bib32","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1056\/NEJMoa2028631","article-title":"Daratumumab-based treatment for immunoglobulin light-chain amyloidosis","volume":"385","author":"Kastritis","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjco.2025.03.015_bib33","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.jchf.2019.07.007","article-title":"A changing landscape of mortality for systemic light chain amyloidosis","volume":"7","author":"Barrett","year":"2019","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cjco.2025.03.015_bib34","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1038\/s41375-018-0060-x","article-title":"Depth of organ response in AL amyloidosis is associated with improved survival: grading the organ response criteria","volume":"32","author":"Muchtar","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.cjco.2025.03.015_bib35","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jaccao.2021.05.007","article-title":"Cardiac transplantation and mechanical circulatory support in amyloidosis","volume":"3","author":"Witteles","year":"2021","journal-title":"JACC CardioOncol"},{"key":"10.1016\/j.cjco.2025.03.015_bib36","doi-asserted-by":"crossref","first-page":"e129","DOI":"10.1016\/j.carpath.2009.06.009","article-title":"Recurrent cardiac amyloidosis following previous heart transplantation","volume":"19","author":"Luk","year":"2010","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.cjco.2025.03.015_bib37","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/ajt.13025","article-title":"Outcomes after heart transplantation for amyloid cardiomyopathy in the modern era","volume":"15","author":"Davis","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cjco.2025.03.015_bib38","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.jacc.2016.06.033","article-title":"Natural history of wild-type transthyretin cardiac amyloidosis and risk stratification using a novel staging system","volume":"68","author":"Grogan","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjco.2025.03.015_bib39","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1093\/eurheartj\/ehx589","article-title":"A new staging system for cardiac transthyretin amyloidosis","volume":"39","author":"Gillmore","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjco.2025.03.015_bib40","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.121.008381","article-title":"Impact of tafamidis and optimal background treatment on physical performance in patients with transthyretin amyloid cardiomyopathy","volume":"15","author":"Badr Eslam","year":"2022","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cjco.2025.03.015_bib41","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","article-title":"Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy","volume":"379","author":"Maurer","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjco.2025.03.015_bib42","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1055\/s-0041-1726285","article-title":"Neurological complications in patients with heart transplantation","volume":"41","author":"Sakusic","year":"2021","journal-title":"Semin Neurol"},{"key":"10.1016\/j.cjco.2025.03.015_bib43","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.healun.2021.10.007","article-title":"Surveillance for disease progression of transthyretin amyloidosis after heart transplantation in the era of novel disease modifying therapies","volume":"41","author":"Griffin","year":"2022","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cjco.2025.03.015_bib44","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.14028","article-title":"United network for organ sharing outcomes after heart transplantation for al compared to ATTR cardiac amyloidosis","volume":"34","author":"Griffin","year":"2020","journal-title":"Clin Transplant"},{"key":"10.1016\/j.cjco.2025.03.015_bib45","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ahj.2021.02.016","article-title":"Cardiac transplantation outcomes in patients with amyloid cardiomyopathy","volume":"236","author":"Ohiomoba","year":"2021","journal-title":"Am Heart J"},{"key":"10.1016\/j.cjco.2025.03.015_bib46","first-page":"461","article-title":"Outcomes in patients with cardiac amyloidosis undergoing heart transplantation","volume":"8","author":"Barrett","year":"2020","journal-title":"J Am Coll Cardiol HF"},{"key":"10.1016\/j.cjco.2025.03.015_bib47","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.healun.2013.01.987","article-title":"Left ventricular device implantation for advanced cardiac amyloidosis","volume":"32","author":"Swiecicki","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cjco.2025.03.015_bib48","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.healun.2015.03.012","article-title":"Role of ventricular assist therapy for patients with heart failure and restrictive physiology: Improving outcomes for a lethal disease","volume":"34","author":"Grupper","year":"2015","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cjco.2025.03.015_bib49","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13663","article-title":"Mechanical circulatory support for cardiac amyloidosis","author":"Kittleson","year":"2019","journal-title":"Clin Transplant"},{"key":"10.1016\/j.cjco.2025.03.015_bib50","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.120.007931","article-title":"Durable mechanical circulatory support in patients with amyloid cardiomyopathy: insights from INTERMACS","volume":"13","author":"Michelis","year":"2020","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cjco.2025.03.015_bib51","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.018866","article-title":"Left ventricular dysfunction in arrhythmogenic right ventricular cardiomyopathy (ARVC): Can we separate ARVC from other arrhythmogenic cardiomyopathies?","volume":"9","author":"Altmayer","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.cjco.2025.03.015_bib52","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1056\/NEJMra1509267","article-title":"Arrhythmogenic right ventricular cardiomyopathy","volume":"376","author":"Corrado","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjco.2025.03.015_bib53","doi-asserted-by":"crossref","first-page":"4782","DOI":"10.3390\/jcm10204782","article-title":"Heart failure in patients with arrhythmogenic cardiomyopathy","volume":"10","author":"Chen","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.cjco.2025.03.015_bib54","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.116.003819","article-title":"Heart failure is common and under-recognized in patients with arrhythmogenic right ventricular cardiomyopathy\/dysplasia","volume":"10","author":"Gilotra","year":"2017","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cjco.2025.03.015_bib55","doi-asserted-by":"crossref","first-page":"e578","DOI":"10.1161\/CIR.0000000000000560","article-title":"Evaluation and management of right-sided heart failure: a scientific statement from the American Heart Association","volume":"137","author":"Konstam","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.cjco.2025.03.015_bib56","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.transproceed.2009.02.010","article-title":"Heart transplantation in arrhythmogenic right ventricular dysplasia: case reports","volume":"41","author":"Fiorelli","year":"2009","journal-title":"Transplant Proc"},{"key":"10.1016\/j.cjco.2025.03.015_bib57","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ijcard.2017.10.076","article-title":"Heart transplantation in arrhythmogenic right ventricular cardiomyopathy\u2014experience from the Nordic ARVC Registry","volume":"250","author":"Gilljam","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cjco.2025.03.015_bib58","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1016\/j.transproceed.2022.08.047","article-title":"Phenotype characterization and course of patients with arrhythmogenic right ventricular cardiomyopathy and biventricular advanced heart failure: a report of 3 cases","volume":"54","author":"Bonios","year":"2022","journal-title":"Transplant Proc"},{"key":"10.1016\/j.cjco.2025.03.015_bib59","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1093\/icvts\/ivu312","article-title":"Over 1200-day support with dual Jarvik 2000 biventricular assist device","volume":"19","author":"Yoshioka","year":"2014","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"10.1016\/j.cjco.2025.03.015_bib60","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1007\/s10047-013-0716-2","article-title":"Arrhythmogenic right ventricular cardiomyopathy: use of a left ventricular assist device as a bridge to transplantation?","volume":"16","author":"Mufti","year":"2013","journal-title":"J Artif Organs"},{"key":"10.1016\/j.cjco.2025.03.015_bib61","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.1023191","article-title":"Continuous-flow left ventricular assist device treatment for arrhythmogenic right ventricular cardiomyopathy complicated by advanced biventricular failure\u2014University of Tokyo experiences","volume":"9","author":"Ono","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.cjco.2025.03.015_bib62","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/aor.13482","article-title":"Long-term support by left ventricular assist device for arrhythmogenic right ventricular cardiomyopathy","volume":"43","author":"Minegishi","year":"2019","journal-title":"Artif Organs"},{"key":"10.1016\/j.cjco.2025.03.015_bib63","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.healun.2020.12.006","article-title":"The results of a single-center experience with HeartMate 3 in a biventricular configuration","volume":"40","author":"McGiffin","year":"2021","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cjco.2025.03.015_bib64","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1002\/ehf2.13757","article-title":"Heart transplantation strategies in arrhythmogenic right ventricular cardiomyopathy: a tertiary ARVC centre experience","volume":"9","author":"Scheel","year":"2022","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.cjco.2025.03.015_bib65","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.cardfail.2016.04.020","article-title":"Survival after heart transplantation in patients with arrhythmogenic right ventricular cardiomyopathy","volume":"23","author":"DePasquale","year":"2017","journal-title":"J Card Fail"},{"key":"10.1016\/j.cjco.2025.03.015_bib66","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1002\/ehf2.13687","article-title":"Heart transplantation outcomes in arrhythmogenic right ventricular cardiomyopathy: a contemporary national analysis","volume":"9","author":"Giuliano","year":"2022","journal-title":"ESC Heart Fail"}],"container-title":["CJC Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589790X25001313?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589790X25001313?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T01:08:07Z","timestamp":1749690487000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589790X25001313"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":66,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S2589790X25001313"],"URL":"https:\/\/doi.org\/10.1016\/j.cjco.2025.03.015","relation":{},"ISSN":["2589-790X"],"issn-type":[{"value":"2589-790X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heart Transplant and Durable Mechanical Circulatory Support for Specific Less-Common Cardiomyopathies","name":"articletitle","label":"Article Title"},{"value":"CJC Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjco.2025.03.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of the Canadian Cardiovascular Society.","name":"copyright","label":"Copyright"}]}}